Geralyn Higgins

1.4k total citations · 1 hit paper
10 papers, 996 citations indexed

About

Geralyn Higgins is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Geralyn Higgins has authored 10 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Geralyn Higgins's work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (4 papers) and Multiple and Secondary Primary Cancers (3 papers). Geralyn Higgins is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (4 papers) and Multiple and Secondary Primary Cancers (3 papers). Geralyn Higgins collaborates with scholars based in United States and Spain. Geralyn Higgins's co-authors include Dean F. Bajorin, John A. McCaffrey, Howard I. Scher, Paul M. Dodd, Madhu Mazumdar, Harry W. Herr, Mary G. Boyle, Melissa Fazzari, Jennifer Bacik and Madhu Mazumdar and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Investigational New Drugs.

In The Last Decade

Geralyn Higgins

10 papers receiving 978 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

1999 540 citations Dean F. Bajorin, Paul M. Dodd et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geralyn Higgins United States	8	914	271	251	152	99	10	996
K M McWhirter United States	6	447 0.5×	310 1.1×	207 0.8×	69 0.5×	61 0.6×	8	746
A. Sáenz Spain	9	482 0.5×	115 0.4×	166 0.7×	51 0.3×	91 0.9×	19	549
Sidney Schultz United States	6	350 0.4×	160 0.6×	180 0.7×	109 0.7×	59 0.6×	12	488
Dallas Williams United States	12	700 0.8×	252 0.9×	131 0.5×	172 1.1×	86 0.9×	24	966
Eugene J. Pietzak United States	15	655 0.7×	182 0.7×	219 0.9×	31 0.2×	254 2.6×	89	869
Elena Farè Italy	13	385 0.4×	113 0.4×	111 0.4×	23 0.2×	92 0.9×	42	482
Kum Cooper South Africa	12	267 0.3×	405 1.5×	88 0.4×	91 0.6×	73 0.7×	19	677
Stephanie A. Mullane United States	12	520 0.6×	431 1.6×	182 0.7×	37 0.2×	156 1.6×	43	785
H Sugao Japan	13	193 0.2×	98 0.4×	259 1.0×	32 0.2×	94 0.9×	56	526
C. Kourousis Greece	13	188 0.2×	445 1.6×	354 1.4×	60 0.4×	69 0.7×	20	641

Countries citing papers authored by Geralyn Higgins

Since Specialization

Citations

This map shows the geographic impact of Geralyn Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geralyn Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geralyn Higgins more than expected).

Fields of papers citing papers by Geralyn Higgins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geralyn Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geralyn Higgins. The network helps show where Geralyn Higgins may publish in the future.

Co-authorship network of co-authors of Geralyn Higgins

This figure shows the co-authorship network connecting the top 25 collaborators of Geralyn Higgins. A scholar is included among the top collaborators of Geralyn Higgins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geralyn Higgins. Geralyn Higgins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Vuky, Jacqueline, Manjit S. Bains, Jennifer Bacik, et al.. (2001). Role of Postchemotherapy Adjunctive Surgery in the Management of Patients With Nonseminoma Arising From the Mediastinum. Journal of Clinical Oncology. 19(3). 682–688. 63 indexed citations

2.

Mazumdar, Madhu, Dean F. Bajorin, Jennifer Bacik, et al.. (2001). Predicting Outcome to Chemotherapy in Patients With Germ Cell Tumors: The Value of the Rate of Decline of Human Chorionic Gonadotrophin and Alpha-Fetoprotein During Therapy. Journal of Clinical Oncology. 19(9). 2534–2541. 83 indexed citations

3.

Bajorin, Dean F., John A. McCaffrey, Paul M. Dodd, et al.. (2000). Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract. Cancer. 88(7). 1671–1678. 2 indexed citations

4.

Bajorin, Dean F., John A. McCaffrey, Paul M. Dodd, et al.. (2000). Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract. Cancer. 88(7). 1671–1678. 85 indexed citations

5.

Dodd, Paul M., et al.. (2000). Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma. Investigational New Drugs. 18(3). 247–251. 19 indexed citations

6.

Dodd, Paul M., John A. McCaffrey, Madhu Mazumdar, et al.. (2000). Evaluation of Drug Delivery and Survival Impact of Dose-Intense Relative to Conventional-Dose Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy in Urothelial Cancer. Cancer Investigation. 18(7). 626–634. 7 indexed citations

7.

Dodd, Paul M., John A. McCaffrey, Madhu Mazumdar, et al.. (1999). Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. Cancer. 85(5). 1145–1150. 9 indexed citations

8.

Dodd, Paul M., John A. McCaffrey, Harry W. Herr, et al.. (1999). Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcinoma. Journal of Clinical Oncology. 17(8). 2546–2546. 118 indexed citations

9.

Bajorin, Dean F., Paul M. Dodd, Madhu Mazumdar, et al.. (1999). Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy. Journal of Clinical Oncology. 17(10). 3173–3181. 540 indexed citations breakdown →

10.

Bajorin, Dean F., John A. McCaffrey, S Hilton, et al.. (1998). Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.. Journal of Clinical Oncology. 16(8). 2722–2727. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact